| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392568A1 Method for the prevention and/or treatment of atherosclerosis |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | CA2361563A1 Use of polyacrylamide gel for forming a connective-tissue capsule in a mammal for cultivating allogenic or xenogenic cells |
| 06/13/2001 | EP1106179A2 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/13/2001 | EP1105734A2 Homer interacting proteins |
| 06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 06/13/2001 | EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 06/13/2001 | EP1105151A1 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives |
| 06/13/2001 | EP1105129A1 Amelioration of apomorphine adverse effects |
| 06/13/2001 | EP1105120A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 06/13/2001 | EP1105104A1 Extended release buccal bioadhesive tablet |
| 06/13/2001 | EP0805812B1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists |
| 06/13/2001 | EP0755382B1 Quinolone derivative for treatment of urinary incontinence |
| 06/13/2001 | EP0725798B1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridoma |
| 06/13/2001 | CN1299361A Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products |
| 06/13/2001 | CN1298736A Medicine for treating man's sterility |
| 06/13/2001 | CN1298731A Process for preparing 'Qianjin' capsule to treat ganopathy |
| 06/13/2001 | CN1298730A Process for preparing 'Qianjin' capsule to treat genopathy |
| 06/13/2001 | CN1298718A Chinese medicine for treating man's sexual disfunction and its preparing process |
| 06/13/2001 | CN1298712A Plaster for treating arthritis, injury, mastitis, sore and furuncle and its preparing process |
| 06/13/2001 | CN1298703A Lubricating cream for copulation and its preparing process |
| 06/13/2001 | CN1067067C 杂环速激肽受体拮抗物 Heterocyclic tachykinin receptor antagonists |
| 06/13/2001 | CN1067065C (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
| 06/13/2001 | CN1066947C Capsule for treating sexual impotence |
| 06/13/2001 | CN1066942C Vaginal antiphlogistic powder, and its prepn. method |
| 06/12/2001 | USRE37224 Immunization of seals |
| 06/12/2001 | US6245916 Useful as neuropeptide y receptor ligands, anxiolytic agents, sedatives, and vasoconstrictors |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245883 An isolated lectin derived peptide; therapy, antiinflammatory agent, suppressing cell adhesion, antimetastasis agents |
| 06/12/2001 | US6245819 Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245808 Oxy-vanadium (IV) complexes having spermicidal activity |
| 06/12/2001 | US6245804 Contraceptives; urogenital disorders |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040255A2 14,15-beta-methylene substituted androgens |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001039766A2 Screening invertebrate pheromones for therapeutic activity |
| 06/07/2001 | WO2001039754A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 06/07/2001 | WO2001039753A1 Transdermal therapeutic systems with improved stability and a method for the production thereof |
| 06/07/2001 | WO2001011971B1 Natural, anti-bacterial, anti-inflammation, anti-virus, anti-herpes cream |
| 06/07/2001 | WO2000032752A9 Psca: prostate stem cell antigen and uses thereof |
| 06/07/2001 | WO2000030629A3 Method of promoting cervical and vaginal secretions |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392402A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390226A1 14,15-beta-methylene substituted androgens |
| 06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104421A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo 3,4-b]pyridine |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
| 06/06/2001 | CN1298406A Condensed thienopyrimidines with phosphodiesterase-V inhibiting action |
| 06/06/2001 | CN1298386A N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders |
| 06/06/2001 | CN1297742A Chinese medicine tincture and its preparation |
| 06/05/2001 | US6242601 Heterocyclic sulfamides |
| 06/05/2001 | US6242568 Zinc finger protein derivatives and methods therefor |
| 06/05/2001 | US6242449 Treating prostatic hypertrophy, urination disorders associated with prostatic hypertrophy, male pattern alopecia, or acne |
| 06/05/2001 | US6242444 5-(2,3-dihydro-5-(4-methylpiperazin-1-ylsulfonyl)-7-benzofuryl )-1-methyl-3-propyl-6,7-dihydro-1h-pyrazolo(4,3-d)pyrimidin-7-one, for example; treatment of inter alia erectile dysfunction. |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 06/05/2001 | US6242212 Nucleotide sequences which code a protein for the diagnosis, detection and treatment of cancer |
| 06/03/2001 | CA2327385A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/03/2001 | CA2327256A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/02/2001 | CA2327164A1 Use of prostaglandin agonists to treat erectile dysfunction or impotence |
| 05/31/2001 | WO2001038503A2 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | WO2001038493A1 Treatment of human infertility |
| 05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001038397A1 N-alkylated peptides having antiangiogenic activity |
| 05/31/2001 | WO2001038355A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 05/31/2001 | WO2001038326A2 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038311A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | WO2001038293A1 Ethers of o-desmethyl venlafaxine |
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037862A2 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias |
| 05/31/2001 | WO2001037848A1 Mixture of pomegranate seed oil and juice products |
| 05/31/2001 | WO2001037846A1 Method and composition for the treatment of adenoviral ocular infections |
| 05/31/2001 | WO2001037841A1 Pharmaceutical compositions comprising trimegestone |
| 05/31/2001 | WO2001037823A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 05/31/2001 | WO2001037808A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | WO2001037780A2 Urotensin-ii analogs |
| 05/31/2001 | WO2001037770A1 Improved transdermal contraceptive delivery system and process |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000069472A3 Enzyme-activated anti-tumor prodrug compounds |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | DE19957156A1 New amino and fluoro substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine derivatives useful in treatment of e.g. arrythmias, spasms, ischaemia, pain and neurodegenerative disorders |
| 05/31/2001 | CA2706113A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | CA2395049A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | CA2394803A1 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | CA2392456A1 Assays and therapies for latent viral infection |
| 05/31/2001 | CA2392327A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 05/31/2001 | CA2392019A1 Method of forming a peptide-receptor complex with zsig33 |
| 05/31/2001 | CA2391288A1 Ethers of o-desmethyl venlafaxine |